Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.
Morikazu MiyamotoMasashi TakanoMika KuwaharaHiroaki SoyamaKento KatoHiroko MatuuraTakahiro SakamotoKazuki TakasakiTadashi AoyamaTomoyuki YoshikawaKenichi FuruyaPublished in: Cancer chemotherapy and pharmacology (2017)
The CPT-N regimen for recurrent and refractory endometrial carcinoma had tolerable side effects and significant efficacy. This regimen is a viable treatment option for endometrial carcinoma.
Keyphrases